menu search

Fiscalnote to present at the 25th annual needham growth conference on january 10, 2023

WASHINGTON--( BUSINESS WIRE )-- FiscalNote Holdings, Inc . (NYSE: NOTE) ("FiscalNote"), a leading AI-driven enterprise Software-as-a-Service (“SaaS�...

January 5, 2023, 7:01 am

Tremor international to present at the needham growth conference

NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Tremor International Ltd. (AIM/NASDAQ: TRMR) (“Tremor” or the “Company”), a global leader in data...

January 5, 2023, 6:30 am

Semrush holdings, inc. to present at the needham growth conference

BOSTON--( BUSINESS WIRE )--Semrush Holdings, Inc. (NYSE: SEMR), a leading online visibility management SaaS platform, announced today that Evgeny Feti...

January 4, 2023, 4:30 pm

Upwork to participate in 25th annual needham growth conference

SAN FRANCISCO, Jan. 03, 2023 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the world’s largest work marketplace that connects businesses with ind...

January 3, 2023, 9:10 pm

Cyclacel pharmaceuticals to present at biotech showcase and participate in a corporate access event during the j.p. morgan healthcare conference in january 2023

BERKELEY HEIGHTS, N.J., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a...

December 15, 2022, 9:15 am

Broadridge to participate in investor conference

NEW YORK , Dec. 2, 2022 /PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE:BR) announced that Edmund Reese, Chief Financial Officer, will be ...

December 2, 2022, 6:25 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Widepoint to present at the ladenburg thalmann virtual tech expo 22 on wednesday, december 7, 2022

FAIRFAX, VA / ACCESSWIRE / November 28, 2022 / WidePoint Corporation (NYSE American:WYY), the innovative technology Managed Solution Provider (MSP) sp...

November 28, 2022, 9:25 am

Spero therapeutics to present at the 5th annual evercore isi healthconx conference

CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical c...

November 22, 2022, 8:05 am

Larimar therapeutics to present at the 34th annual piper sandler healthcare conference

BALA CYNWYD, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company ...

November 21, 2022, 4:05 pm

Cardiff oncology to present at upcoming investor conferences

SAN DIEGO , Nov. 21, 2022 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to ...

November 21, 2022, 10:52 am


Search within

Pages Search Results: